Macrogol En Elektrolyten Aurobindo

Macrogol 3350, the active ingredient in Macrogol En Elektrolyten Aurobindo, is an osmotic laxative presented as an oral solution for oral use. It treats constipation and is used to prepare the bowel before diagnostic procedures in adults and children.

GNH USA supplies Macrogol En Elektrolyten Aurobindo as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Macrogol En Elektrolyten Aurobindo, an osmotic laxative, is used to manage conditions that require bowel cleansing or relief of constipation. - Constipation: facilitates soft stool formation and promotes regular bowel movements. - Bowel preparation for colonoscopy: provides effective intestinal cleansing to improve visualization. - Pre‑operative bowel cleansing: clears the colon before abdominal surgery to reduce infection risk.

Macrogol En Elektrolyten Aurobindo may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal bloating: feeling of fullness or distension in the abdomen. - Flatulence: increased intestinal gas. - Nausea: mild sensation of queasiness. - Diarrhea: loose stools, especially with higher doses.

Serious or Rare Side Effects: - Electrolyte imbalance: abnormal serum sodium or potassium levels. - Severe dehydration: marked loss of body fluids. - Allergic reaction: rash, itching, swelling, or difficulty breathing.

When using Macrogol En Elektrolyten Aurobindo, consider the following precautions. - Renal impairment: monitor fluid and electrolyte status. - Heart failure: avoid excessive fluid shifts. - Pregnancy and lactation: use only if clearly needed. - Elderly patients: start with lower dose to reduce risk of dehydration. - Concurrent laxatives: avoid combining to prevent electrolyte disturbances. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Macrogol En Elektrolyten Aurobindo can interact with other medicines; awareness of the interaction level is important.

Major Interactions (Avoid): - Loop diuretics: may exacerbate electrolyte loss and dehydration. - Sodium‑containing medications: can increase risk of hypernatremia.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may reduce efficacy of bowel cleansing. - Opioid analgesics: may counteract laxative effect, requiring dose adjustment. - Mineral supplements (e.g., calcium, iron): may bind to the solution and reduce effectiveness.